From macroscopic clearance to molecular eradication: paradigm shift and future perspectives in the detecting of residual lesions after transurethral resection of bladder tumors
Future priorities include standardizing diagnostic workflows, improving multi-omics integration and validating MRD-guided strategies in prospective studies. These developments may refine risk stratification, reduce recurrence, and support more personalized postoperative management in bladder cancer.
Authors
- Jiangwei Man
- Yalong Zhang (ORCID: https://orcid.org/0000-0002-9995-7659)
- Rui Yan (ORCID: https://orcid.org/0000-0001-8746-2483)
- Yang Li (ORCID: https://orcid.org/0000-0002-3182-6169)
- Hao Wang (ORCID: https://orcid.org/0000-0001-9425-4666)
Institutions
- Gansu Provincial Center for Disease Control and Prevention (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Expert Review of Anticancer Therapy
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1080/14737140.2025.2597526
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00